Trial · NCT03129100
Participant flow598
How many started, completed or left each group, period by period.
1 to 20 of 598
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Lead-In Period (Period 1) | STARTED | IXE 80Q4W-Lead-in Period | 350 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W-Lead-in Period | 423 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W-Group A Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W-Group A Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W-Group B-Randomized Withdrawal Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W-Group B-Randomized Withdrawal Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | Placebo-Group B-Randomized Withdrawal Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W/IXE80Q2W-Retreatment Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W/IXE80Q4W-Retreatment Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | PBO/IXE80Q2W-Retreatment Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | PBO/IXE80Q4W-Retreatment Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W-group A Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W-group A Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W-Group B-Randomized Withdrawal Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W-Group B-Randomized Withdrawal Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | PBO-Group B-Randomized Withdrawal Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q2W/IXE80Q2W-Retreatment Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | IXE80Q4W/IXE80Q4W-Retreatment Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | PBO/IXE80Q2W-Retreatment Long-term Extension Period | 0 | |
| Lead-In Period (Period 1) | STARTED | PBO/IXE80Q4W-Retreatment Long-term Extension Period | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03129100/flow